Global Blockchain in Pharmaceutical
Global Blockchain in Pharmaceutical

Blockchain in Pharmaceutical Comprehensive Study by Type (Public, Private, Consortium), Application (Supply Chain Management, Clinical Data Exchange and Interoperability, Drug Development, Clinical Trials, Others), End-User (Pharmaceutical Companies, Healthcare Payers, Healthcare Providers) Players and Region - Global Market Outlook to 2026

Blockchain in Pharmaceutical Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Jan 2021 Edition 217 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Blockchain in Pharmaceutical Market Scope?
Blockchain is rapidly gaining interest and has been lauded for its wide-ranging applications, largely due to its recent expansion in industries ranging from financial services to utilities to pharmaceutical companies. Blockchain is almost a decade old. Its presence was felt in almost all sectors. It is highly applicable to various use cases ranging from financial services to real estate. The winners here are the companies that use it to improve their processes. The pharmaceutical industry is an important part of the healthcare system. It's a USD 482 billion industry. Without them, there would be no drug development, distribution, or discovery. When we talk about the pharmaceutical sector, we mean these three things: sales, development, and the discovery process. Blockchain solves almost all challenges and problems in the pharmaceutical industry. The blockchain pharmacy can move to a new type of infrastructure when companies start adopting it. Blockchain can modernize the pharmaceutical industry as it introduces three key elements for the privacy, transparency, and traceability of the industry. It will help with the laws, practices, privacy regulations, and global regulations of the industry. It can also help pharmaceuticals track and trace drugs using the blockchain. There are many benefits to using blockchain in the pharmaceutical supply chain. The pharmaceutical supply chain is one of the top concerns of pharmaceutical companies. Blockchain also offers smart contracts. Smart contracts offer the possibility to automate tasks in the blockchain. This is very useful as the smart contracts can execute notifications when the compliance conditions are not met.

The Blockchain in Pharmaceutical market study is being classified by Type (Public, Private and Consortium), by Application (Supply Chain Management, Clinical Data Exchange and Interoperability, Drug Development, Clinical Trials and Others) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Blockchain in Pharmaceutical market throughout the predicted period.

IBM Corporation (United States), AWS (United States), Microsoft Corporation (United States), SAP (Germany), Chronicled (United States), Huawei (China), Doc.AI Inc. (United States), Embleema (United States), Factom Inc. (United States), FarmaTrust (United Kingdom) and Guardtime Federal (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Hashed Health (United States) and Medicalchain (United Kingdom).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Blockchain in Pharmaceutical market by Type, Application and Region.

On the basis of geography, the market of Blockchain in Pharmaceutical has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In March 2019, Embleema, Inc. had signed an agreement for partnership with a leading cancer institute of Europe, Gustave Roussy Institut. The partnership was thereby aimed at building a blockchain-based platform for the purpose of secure exchange of healthcare outcomes and patient data of oncology research, thereby assisting clinical studies.

On June 13, 2019, IBM announced with KPMG, Merck, and Walmart that the companies had been selected by the US Food and Drug Administration (FDA) to participate in a program in support of the US Drug Supply Chain Security Act (DSCSA), which meets requirements to identify, track, and track prescription drugs and vaccines that should be marketed within the United States. The program was designed to assist drug supply chain stakeholders, including the FDA, in developing an electronic, interoperable system to identify and track certain prescription drugs when they are marketed in the United States.

Influencing Market Trend
  • The Rapid Economic Expansion of the Pharmaceutical and Healthcare Industries Worldwide
  • Increasing Awareness about Blockchain Technology

Market Drivers
  • The Rising Awareness about the Importance of Blockchain Technology for Systematic Collection
  • Enhancement in the Drug Supply Chain Process by Ensuring the Validity and Distribution
  • Stringent Regulatory Rules and Regulations Coupled With Increasing Incidence of Data Breach

Opportunities
  • Increasing Research and Development Expenditure in Pharmaceutical Industry
  • Rising Technological, Transportation and Medical Breakthroughs

Restraints
  • A Dearth of Shared Data Architecture

Challenges
  • Lack of Structured Inter-System Communication Protocol


Key Target Audience
Providers of Blockchain in Pharmaceutical, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Public
  • Private
  • Consortium
By Application
  • Supply Chain Management
  • Clinical Data Exchange and Interoperability
  • Drug Development
  • Clinical Trials
  • Others
By End-User
  • Pharmaceutical Companies
  • Healthcare Payers
  • Healthcare Providers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Awareness about the Importance of Blockchain Technology for Systematic Collection
      • 3.2.2. Enhancement in the Drug Supply Chain Process by Ensuring the Validity and Distribution
      • 3.2.3. Stringent Regulatory Rules and Regulations Coupled With Increasing Incidence of Data Breach
    • 3.3. Market Challenges
      • 3.3.1. Lack of Structured Inter-System Communication Protocol
    • 3.4. Market Trends
      • 3.4.1. The Rapid Economic Expansion of the Pharmaceutical and Healthcare Industries Worldwide
      • 3.4.2. Increasing Awareness about Blockchain Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blockchain in Pharmaceutical, by Type, Application, End-User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blockchain in Pharmaceutical (Value)
      • 5.2.1. Global Blockchain in Pharmaceutical by: Type (Value)
        • 5.2.1.1. Public
        • 5.2.1.2. Private
        • 5.2.1.3. Consortium
      • 5.2.2. Global Blockchain in Pharmaceutical by: Application (Value)
        • 5.2.2.1. Supply Chain Management
        • 5.2.2.2. Clinical Data Exchange and Interoperability
        • 5.2.2.3. Drug Development
        • 5.2.2.4. Clinical Trials
        • 5.2.2.5. Others
      • 5.2.3. Global Blockchain in Pharmaceutical by: End-User (Value)
        • 5.2.3.1. Pharmaceutical Companies
        • 5.2.3.2. Healthcare Payers
        • 5.2.3.3. Healthcare Providers
      • 5.2.4. Global Blockchain in Pharmaceutical Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blockchain in Pharmaceutical (Price)
      • 5.3.1. Global Blockchain in Pharmaceutical by: Type (Price)
  • 6. Blockchain in Pharmaceutical: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IBM Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. AWS (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Microsoft Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. SAP (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Chronicled (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Huawei (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Doc.AI Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Embleema (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Factom Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. FarmaTrust (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Guardtime Federal (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Blockchain in Pharmaceutical Sale, by Type, Application, End-User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blockchain in Pharmaceutical (Value)
      • 7.2.1. Global Blockchain in Pharmaceutical by: Type (Value)
        • 7.2.1.1. Public
        • 7.2.1.2. Private
        • 7.2.1.3. Consortium
      • 7.2.2. Global Blockchain in Pharmaceutical by: Application (Value)
        • 7.2.2.1. Supply Chain Management
        • 7.2.2.2. Clinical Data Exchange and Interoperability
        • 7.2.2.3. Drug Development
        • 7.2.2.4. Clinical Trials
        • 7.2.2.5. Others
      • 7.2.3. Global Blockchain in Pharmaceutical by: End-User (Value)
        • 7.2.3.1. Pharmaceutical Companies
        • 7.2.3.2. Healthcare Payers
        • 7.2.3.3. Healthcare Providers
      • 7.2.4. Global Blockchain in Pharmaceutical Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blockchain in Pharmaceutical (Price)
      • 7.3.1. Global Blockchain in Pharmaceutical by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blockchain in Pharmaceutical: by Type(USD Million)
  • Table 2. Blockchain in Pharmaceutical Public , by Region USD Million (2015-2020)
  • Table 3. Blockchain in Pharmaceutical Private , by Region USD Million (2015-2020)
  • Table 4. Blockchain in Pharmaceutical Consortium , by Region USD Million (2015-2020)
  • Table 5. Blockchain in Pharmaceutical: by Application(USD Million)
  • Table 6. Blockchain in Pharmaceutical Supply Chain Management , by Region USD Million (2015-2020)
  • Table 7. Blockchain in Pharmaceutical Clinical Data Exchange and Interoperability , by Region USD Million (2015-2020)
  • Table 8. Blockchain in Pharmaceutical Drug Development , by Region USD Million (2015-2020)
  • Table 9. Blockchain in Pharmaceutical Clinical Trials , by Region USD Million (2015-2020)
  • Table 10. Blockchain in Pharmaceutical Others , by Region USD Million (2015-2020)
  • Table 11. Blockchain in Pharmaceutical: by End-User(USD Million)
  • Table 12. Blockchain in Pharmaceutical Pharmaceutical Companies , by Region USD Million (2015-2020)
  • Table 13. Blockchain in Pharmaceutical Healthcare Payers , by Region USD Million (2015-2020)
  • Table 14. Blockchain in Pharmaceutical Healthcare Providers , by Region USD Million (2015-2020)
  • Table 15. South America Blockchain in Pharmaceutical, by Country USD Million (2015-2020)
  • Table 16. South America Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 17. South America Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 18. South America Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 19. Brazil Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 20. Brazil Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 21. Brazil Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 22. Argentina Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 23. Argentina Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 24. Argentina Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 25. Rest of South America Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 26. Rest of South America Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 27. Rest of South America Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 28. Asia Pacific Blockchain in Pharmaceutical, by Country USD Million (2015-2020)
  • Table 29. Asia Pacific Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 30. Asia Pacific Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 31. Asia Pacific Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 32. China Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 33. China Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 34. China Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 35. Japan Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 36. Japan Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 37. Japan Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 38. India Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 39. India Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 40. India Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 41. South Korea Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 42. South Korea Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 43. South Korea Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 44. Taiwan Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 45. Taiwan Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 46. Taiwan Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 47. Australia Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 48. Australia Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 49. Australia Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 53. Europe Blockchain in Pharmaceutical, by Country USD Million (2015-2020)
  • Table 54. Europe Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 55. Europe Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 56. Europe Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 57. Germany Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 58. Germany Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 59. Germany Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 60. France Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 61. France Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 62. France Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 63. Italy Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 64. Italy Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 65. Italy Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 66. United Kingdom Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 67. United Kingdom Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 68. United Kingdom Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 69. Netherlands Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 70. Netherlands Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 71. Netherlands Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 72. Rest of Europe Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 73. Rest of Europe Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 74. Rest of Europe Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 75. MEA Blockchain in Pharmaceutical, by Country USD Million (2015-2020)
  • Table 76. MEA Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 77. MEA Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 78. MEA Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 79. Middle East Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 80. Middle East Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 81. Middle East Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 82. Africa Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 83. Africa Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 84. Africa Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 85. North America Blockchain in Pharmaceutical, by Country USD Million (2015-2020)
  • Table 86. North America Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 87. North America Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 88. North America Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 89. United States Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 90. United States Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 91. United States Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 92. Canada Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 93. Canada Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 94. Canada Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 95. Mexico Blockchain in Pharmaceutical, by Type USD Million (2015-2020)
  • Table 96. Mexico Blockchain in Pharmaceutical, by Application USD Million (2015-2020)
  • Table 97. Mexico Blockchain in Pharmaceutical, by End-User USD Million (2015-2020)
  • Table 98. Blockchain in Pharmaceutical: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Blockchain in Pharmaceutical: by Type(USD Million)
  • Table 111. Blockchain in Pharmaceutical Public , by Region USD Million (2021-2026)
  • Table 112. Blockchain in Pharmaceutical Private , by Region USD Million (2021-2026)
  • Table 113. Blockchain in Pharmaceutical Consortium , by Region USD Million (2021-2026)
  • Table 114. Blockchain in Pharmaceutical: by Application(USD Million)
  • Table 115. Blockchain in Pharmaceutical Supply Chain Management , by Region USD Million (2021-2026)
  • Table 116. Blockchain in Pharmaceutical Clinical Data Exchange and Interoperability , by Region USD Million (2021-2026)
  • Table 117. Blockchain in Pharmaceutical Drug Development , by Region USD Million (2021-2026)
  • Table 118. Blockchain in Pharmaceutical Clinical Trials , by Region USD Million (2021-2026)
  • Table 119. Blockchain in Pharmaceutical Others , by Region USD Million (2021-2026)
  • Table 120. Blockchain in Pharmaceutical: by End-User(USD Million)
  • Table 121. Blockchain in Pharmaceutical Pharmaceutical Companies , by Region USD Million (2021-2026)
  • Table 122. Blockchain in Pharmaceutical Healthcare Payers , by Region USD Million (2021-2026)
  • Table 123. Blockchain in Pharmaceutical Healthcare Providers , by Region USD Million (2021-2026)
  • Table 124. South America Blockchain in Pharmaceutical, by Country USD Million (2021-2026)
  • Table 125. South America Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 126. South America Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 127. South America Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 128. Brazil Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 129. Brazil Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 130. Brazil Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 131. Argentina Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 132. Argentina Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 133. Argentina Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 134. Rest of South America Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 135. Rest of South America Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 136. Rest of South America Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 137. Asia Pacific Blockchain in Pharmaceutical, by Country USD Million (2021-2026)
  • Table 138. Asia Pacific Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 139. Asia Pacific Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 140. Asia Pacific Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 141. China Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 142. China Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 143. China Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 144. Japan Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 145. Japan Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 146. Japan Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 147. India Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 148. India Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 149. India Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 150. South Korea Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 151. South Korea Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 152. South Korea Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 153. Taiwan Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 154. Taiwan Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 155. Taiwan Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 156. Australia Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 157. Australia Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 158. Australia Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 162. Europe Blockchain in Pharmaceutical, by Country USD Million (2021-2026)
  • Table 163. Europe Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 164. Europe Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 165. Europe Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 166. Germany Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 167. Germany Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 168. Germany Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 169. France Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 170. France Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 171. France Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 172. Italy Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 173. Italy Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 174. Italy Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 175. United Kingdom Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 176. United Kingdom Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 177. United Kingdom Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 178. Netherlands Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 179. Netherlands Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 180. Netherlands Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 181. Rest of Europe Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 182. Rest of Europe Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 183. Rest of Europe Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 184. MEA Blockchain in Pharmaceutical, by Country USD Million (2021-2026)
  • Table 185. MEA Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 186. MEA Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 187. MEA Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 188. Middle East Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 189. Middle East Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 190. Middle East Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 191. Africa Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 192. Africa Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 193. Africa Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 194. North America Blockchain in Pharmaceutical, by Country USD Million (2021-2026)
  • Table 195. North America Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 196. North America Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 197. North America Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 198. United States Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 199. United States Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 200. United States Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 201. Canada Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 202. Canada Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 203. Canada Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 204. Mexico Blockchain in Pharmaceutical, by Type USD Million (2021-2026)
  • Table 205. Mexico Blockchain in Pharmaceutical, by Application USD Million (2021-2026)
  • Table 206. Mexico Blockchain in Pharmaceutical, by End-User USD Million (2021-2026)
  • Table 207. Blockchain in Pharmaceutical: by Type(USD/Units)
  • Table 208. Research Programs/Design for This Report
  • Table 209. Key Data Information from Secondary Sources
  • Table 210. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blockchain in Pharmaceutical: by Type USD Million (2015-2020)
  • Figure 5. Global Blockchain in Pharmaceutical: by Application USD Million (2015-2020)
  • Figure 6. Global Blockchain in Pharmaceutical: by End-User USD Million (2015-2020)
  • Figure 7. South America Blockchain in Pharmaceutical Share (%), by Country
  • Figure 8. Asia Pacific Blockchain in Pharmaceutical Share (%), by Country
  • Figure 9. Europe Blockchain in Pharmaceutical Share (%), by Country
  • Figure 10. MEA Blockchain in Pharmaceutical Share (%), by Country
  • Figure 11. North America Blockchain in Pharmaceutical Share (%), by Country
  • Figure 12. Global Blockchain in Pharmaceutical: by Type USD/Units (2015-2020)
  • Figure 13. Global Blockchain in Pharmaceutical share by Players 2020 (%)
  • Figure 14. Global Blockchain in Pharmaceutical share by Players (Top 3) 2020(%)
  • Figure 15. Global Blockchain in Pharmaceutical share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. IBM Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. IBM Corporation (United States) Revenue: by Geography 2020
  • Figure 19. AWS (United States) Revenue, Net Income and Gross profit
  • Figure 20. AWS (United States) Revenue: by Geography 2020
  • Figure 21. Microsoft Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Microsoft Corporation (United States) Revenue: by Geography 2020
  • Figure 23. SAP (Germany) Revenue, Net Income and Gross profit
  • Figure 24. SAP (Germany) Revenue: by Geography 2020
  • Figure 25. Chronicled (United States) Revenue, Net Income and Gross profit
  • Figure 26. Chronicled (United States) Revenue: by Geography 2020
  • Figure 27. Huawei (China) Revenue, Net Income and Gross profit
  • Figure 28. Huawei (China) Revenue: by Geography 2020
  • Figure 29. Doc.AI Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Doc.AI Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Embleema (United States) Revenue, Net Income and Gross profit
  • Figure 32. Embleema (United States) Revenue: by Geography 2020
  • Figure 33. Factom Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Factom Inc. (United States) Revenue: by Geography 2020
  • Figure 35. FarmaTrust (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. FarmaTrust (United Kingdom) Revenue: by Geography 2020
  • Figure 37. Guardtime Federal (United States) Revenue, Net Income and Gross profit
  • Figure 38. Guardtime Federal (United States) Revenue: by Geography 2020
  • Figure 39. Global Blockchain in Pharmaceutical: by Type USD Million (2021-2026)
  • Figure 40. Global Blockchain in Pharmaceutical: by Application USD Million (2021-2026)
  • Figure 41. Global Blockchain in Pharmaceutical: by End-User USD Million (2021-2026)
  • Figure 42. South America Blockchain in Pharmaceutical Share (%), by Country
  • Figure 43. Asia Pacific Blockchain in Pharmaceutical Share (%), by Country
  • Figure 44. Europe Blockchain in Pharmaceutical Share (%), by Country
  • Figure 45. MEA Blockchain in Pharmaceutical Share (%), by Country
  • Figure 46. North America Blockchain in Pharmaceutical Share (%), by Country
  • Figure 47. Global Blockchain in Pharmaceutical: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • IBM Corporation (United States)
  • AWS (United States)
  • Microsoft Corporation (United States)
  • SAP (Germany)
  • Chronicled (United States)
  • Huawei (China)
  • Doc.AI Inc. (United States)
  • Embleema (United States)
  • Factom Inc. (United States)
  • FarmaTrust (United Kingdom)
  • Guardtime Federal (United States)
Additional players considered in the study are as follows:
Hashed Health (United States) , Medicalchain (United Kingdom)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation